Continuing support is requested for the University of California, Irvine's Gynecologic Oncology Fellowship program. This fellowship program, administered by UCI's NCI-designated Chao Family Comprehensive Cancer Center, is entering its 19th year. The Gynecologic Oncology Fellowship program is geared toward training physician scientists in the sub-specialty of gynecologic oncology by providing multiple levels of interaction between basic and clinical scientists to facilitate the transfer and exchange of information. The fellowship program provides trainees with opportunities for the practice application of skills in the design and testing of scientific hypotheses. Trainees receive three years of research training, consisting of two years training in the basic sciences followed by one year of clinical/translational research training. There are 31 training faculty, made up of 21 basic scientists and 10 clinical researchers from 10 departments in the School of Biological Sciences and College of Medicine. Faculty mentors have research concentrations in the following areas: photomedicine, structural molecular biology, growth factors and signaling, cell transformation and carcinogenesis, cancer epidemiology and cancer genetics, cancer screening and prevention, and experimental therapeutics. Twenty-seven of the training faculty have active, peer- received, research grants. Support is requested for 5 postdoctoral fellowship positions. Competition is keen for the one to two available fellowship positions annually. Recruitment for the fellowship program draws from the 1,200 Obstetrics and Gynecology residency positions nationwide. Over 90% of the graduated fellows from the program have gone on to academic faculty positions. Training features of the program included didactic coursework in the areas of responsible conduct of research, biostatistics and epidemiology, and cancer-related elective, national scientific meetings, and numerous other multi-disciplinary seminars, lectures and symposia.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA060396-10
Application #
6603092
Study Section
Subcommittee G - Education (NCI)
Program Officer
Gorelic, Lester S
Project Start
1994-09-26
Project End
2004-06-30
Budget Start
2003-05-01
Budget End
2004-06-30
Support Year
10
Fiscal Year
2003
Total Cost
$298,469
Indirect Cost
Name
University of California Irvine
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
Wolford, Juliet E; Tewari, Krishnansu S (2018) Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer. Expert Opin Drug Discov 13:445-457
Minion, Lindsey E; Tewari, Krishnansu S (2018) Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition. Gynecol Oncol 148:609-621
Pfaendler, Krista S; Chang, Jenny; Ziogas, Argyrios et al. (2018) Disparities in Adherence to National Comprehensive Cancer Network Treatment Guidelines and Survival for Stage IB-IIA Cervical Cancer in California. Obstet Gynecol 131:899-908
Wolford, Juliet E; Tewari, Krishnansu S (2017) Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology. J Gynecol Oncol 28:e74
Pfaendler, Krista S; Tewari, Krishnansu S (2016) Changing paradigms in the systemic treatment of advanced cervical cancer. Am J Obstet Gynecol 214:22-30
Eskander, Ramez N; Ali, Shamshad; Dellinger, Thanh et al. (2016) Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Int J Gynecol Cancer 26:125-32
Longoria, Teresa C; Tewari, Krishnansu S (2016) Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanoma. Expert Opin Drug Metab Toxicol 12:1247-53
Galvan-Turner, Valerie B; Chang, Jenny; Ziogas, Argyrios et al. (2015) Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer. Gynecol Oncol 139:495-9
Longoria, Teresa C; Tewari, Krishnansu S (2015) Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations. Drugs 75:1853-65
Parham, Groesbeck P; Mwanahamuntu, Mulindi H; Kapambwe, Sharon et al. (2015) Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. PLoS One 10:e0122169

Showing the most recent 10 out of 25 publications